Maze Therapeutics Statistics
Total Valuation
MAZE has a market cap or net worth of $1.48 billion. The enterprise value is $1.18 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.18B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAZE has 55.35 million shares outstanding. The number of shares has increased by 449.59% in one year.
| Current Share Class | 55.35M |
| Shares Outstanding | 55.35M |
| Shares Change (YoY) | +449.59% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 62.95% |
| Float | 37.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.75 |
| Forward PS | 306.12 |
| PB Ratio | 3.81 |
| P/TBV Ratio | 4.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 59.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.88, with a Debt / Equity ratio of 0.18.
| Current Ratio | 17.88 |
| Quick Ratio | 17.62 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -154.79 |
Financial Efficiency
Return on equity (ROE) is -38.67% and return on invested capital (ROIC) is -308.53%.
| Return on Equity (ROE) | -38.67% |
| Return on Assets (ROA) | -22.27% |
| Return on Invested Capital (ROIC) | -308.53% |
| Return on Capital Employed (ROCE) | -33.64% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $141,844 |
| Profits Per Employee | -$869,092 |
| Employee Count | 141 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +148.56% |
| 50-Day Moving Average | 25.71 |
| 200-Day Moving Average | 33.97 |
| Relative Strength Index (RSI) | 58.20 |
| Average Volume (20 Days) | 568,235 |
Short Selling Information
The latest short interest is 3.90 million, so 7.04% of the outstanding shares have been sold short.
| Short Interest | 3.90M |
| Short Previous Month | 3.95M |
| Short % of Shares Out | 7.04% |
| Short % of Float | 10.48% |
| Short Ratio (days to cover) | 7.83 |
Income Statement
In the last 12 months, MAZE had revenue of $20.00 million and -$122.54 million in losses. Loss per share was -$2.49.
| Revenue | 20.00M |
| Gross Profit | 20.00M |
| Operating Income | -134.05M |
| Pretax Income | -122.54M |
| Net Income | -122.54M |
| EBITDA | -131.89M |
| EBIT | -134.05M |
| Loss Per Share | -$2.49 |
Balance Sheet
The company has $352.38 million in cash and $61.22 million in debt, with a net cash position of $291.16 million or $5.26 per share.
| Cash & Cash Equivalents | 352.38M |
| Total Debt | 61.22M |
| Net Cash | 291.16M |
| Net Cash Per Share | $5.26 |
| Equity (Book Value) | 341.70M |
| Book Value Per Share | 6.93 |
| Working Capital | 358.54M |
Cash Flow
In the last 12 months, operating cash flow was -$121.54 million and capital expenditures -$588,000, giving a free cash flow of -$122.13 million.
| Operating Cash Flow | -121.54M |
| Capital Expenditures | -588,000 |
| Depreciation & Amortization | 2.16M |
| Net Borrowing | 39.40M |
| Free Cash Flow | -122.13M |
| FCF Per Share | -$2.21 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -670.26% |
| Pretax Margin | -612.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MAZE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -449.59% |
| Shareholder Yield | -449.59% |
| Earnings Yield | -8.31% |
| FCF Yield | -8.28% |
Analyst Forecast
The average price target for MAZE is $62.55, which is 134.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $62.55 |
| Price Target Difference | 134.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MAZE has an Altman Z-Score of 7.74 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.74 |
| Piotroski F-Score | 2 |